These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33590389)

  • 21. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.
    Matsumura T; Arai M; Suzuki T; Hoppo T; Seki Y; Kasamatsu S; Ishigami H; Ishikawa K; Okimoto K; Akizue N; Maruoka D; Nakagawa T; Odaka T; Okamoto Y; Kato N
    Esophagus; 2020 Jul; 17(3):339-347. PubMed ID: 31982992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esophageal pH increments associated with post-reflux swallow-induced peristaltic waves show the occurrence and relevance of esophago-salivary reflex in clinical setting.
    Frazzoni M; Frazzoni L; Ribolsi M; De Bortoli N; Tolone S; Conigliaro R; Arsiè E; Penagini R; Cicala M; Savarino E
    Neurogastroenterol Motil; 2021 Jul; 33(7):e14085. PubMed ID: 33471424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.
    Akiyama J; Hosaka H; Kuribayashi S; Moriyasu S; Hisada Y; Okubo H; Watanabe K; Imbe K; Nagata N; Kojima Y; Yokoi C; Uemura N; Shimoyama Y; Kawamura O; Yamada M; Kusano M
    Digestion; 2020; 101(2):174-183. PubMed ID: 30897577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of proton pump inhibitors on autonomic tone in patients with erosive and non-erosive esophagitis.
    Jones EL; Perring S; Khattab A; Allenby-Smith O
    Neurogastroenterol Motil; 2016 May; 28(5):659-64. PubMed ID: 26748487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with prevalence and severity of erosive tooth wear in patients with reflux oesophagitis.
    Kitasako Y; Momma E; Tanabe T; Koeda M; Hoshikawa Y; Hoshino S; Kawami N; Ikeda M; Iwakiri K
    J Oral Rehabil; 2024 Aug; 51(8):1357-1364. PubMed ID: 38651199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of pH reflux monitoring test for the management of low-grade esophagitis in Chinese patients.
    Qiu B; Zhang X; Bai T; Xu J; Xiang X; Hou X
    Neurogastroenterol Motil; 2019 Sep; 31(9):e13653. PubMed ID: 31157483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis.
    Hoshino S; Kawami N; Takenouchi N; Umezawa M; Hanada Y; Hoshikawa Y; Kawagoe T; Sano H; Hoshihara Y; Nomura T; Iwakiri K
    Digestion; 2017; 95(2):156-161. PubMed ID: 28190016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of salivary and seric epidermal growth factor in pathogenesis of reflux esophagitis in chronic alcoholics and nondrinkers.
    Benamouzig R; Ferrière F; Guettier C; Amouroux J; Coste T; Rautureau J
    Dig Dis Sci; 1996 Aug; 41(8):1595-9. PubMed ID: 8769285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Reflux in the Pathogenesis of Eosinophilic Esophagitis: Comprehensive Appraisal With Off- and On PPI Impedance-pH Monitoring.
    Frazzoni M; Penagini R; Frazzoni L; de Bortoli N; Mauro A; Tolone S; Bertani H; Marsico M; Marocchi M; Marchi S; Conigliaro R; Savarino E
    Am J Gastroenterol; 2019 Oct; 114(10):1606-1613. PubMed ID: 31449157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
    Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
    Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is proton pump inhibitor therapy for reflux esophagitis sufficient?: a large real-world survey of Japanese patients.
    Higuchi K; Joh T; Nakada K; Haruma K
    Intern Med; 2013; 52(13):1447-54. PubMed ID: 23812190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of eosinophilic oesophagitis to proton pump inhibitors is associated with impedance-pH parameters implying anti-reflux mechanism of action.
    Frazzoni M; Frazzoni L; De Bortoli N; Russo S; Tolone S; Arsiè E; Conigliaro R; Penagini R; Savarino E
    Aliment Pharmacol Ther; 2021 Jun; 53(11):1183-1189. PubMed ID: 33857331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary secretion in reflux esophagitis.
    Sonnenberg A; Steinkamp U; Weise A; Berges W; Wienbeck M; Rohner HG; Peter P
    Gastroenterology; 1982 Oct; 83(4):889-95. PubMed ID: 7106518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors.
    Monaco L; Brillantino A; Torelli F; Schettino M; Izzo G; Cosenza A; Di Martino N
    World J Gastroenterol; 2009 Jan; 15(3):334-8. PubMed ID: 19140233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esophageal physiologic profiles within erosive esophagitis in China: Predominantly low-grade esophagitis with low reflux burden.
    Zhang M; Tan N; Li Y; Chen M; Xiao Y
    Neurogastroenterol Motil; 2019 Dec; 31(12):e13702. PubMed ID: 31407469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of esophageal motility abnormalities in severe reflux esophagitis].
    Xu JY; Xie XP; Hou XH
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):353-5. PubMed ID: 16009005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes.
    Dunbar KB; Agoston AT; Odze RD; Huo X; Pham TH; Cipher DJ; Castell DO; Genta RM; Souza RF; Spechler SJ
    JAMA; 2016 May; 315(19):2104-12. PubMed ID: 27187303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH-Impedance Findings and proton pump inhibitors-responsiveness in patients with typical gastroesophageal reflux disease symptoms in a large single-center Italian series.
    Vailati C; Mazzoleni G; Testoni PA; Passaretti S
    J Clin Gastroenterol; 2014 Aug; 48(7):613-9. PubMed ID: 24326754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphisms of CYP2C19 and IL1B have no influence on esomeprazole treatment for mild erosive esophagitis.
    Hsu WH; Kuo FC; Hu HM; Hsu PI; Wu DC; Kuo CH
    Kaohsiung J Med Sci; 2015 May; 31(5):255-9. PubMed ID: 25910560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.